Risk/Benefit Assessment of Tamoxifen to Prevent Breast CancerStill a Work in Progress?
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/91/21/1792/8118978/1792.pdf
Reference5 articles.
1. Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
2. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
3. Stroke Incidence and Survival Among Middle-Aged Adults
4. The cardiovascular health study: Design and rationale
5. Differences in Prevalence of and Risk Factors for Subclinical Vascular Disease Among Black and White Participants in the Cardiovascular Health Study
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agents;European Journal of Medicinal Chemistry;2020-12
2. Cultural Connections: the Key to Retention of Black, Latina, and Arab Women in the Kin KeeperSM Cancer Prevention Intervention Studies;Journal of Cancer Education;2015-07-01
3. Benefit/Risk Assessment in Prevention Trials;Wiley StatsRef: Statistics Reference Online;2014-09-29
4. Benefit/Risk Assessment in Prevention Trials;Methods and Applications of Statistics in Clinical Trials;2014-09-26
5. Chemoprevention Activity of Dipyridamole in the MMTV-PyMT Transgenic Mouse Model of Breast Cancer;Cancer Prevention Research;2013-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3